Tissue distribution of the opioid receptor-like (ORL1) receptor

Peptides

Volumn 21, Issue 7, 2000, Pages 907-917

  Mollereau, Catherine ^a   Mouledous, Lionel ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Anatomic distribution; G protein coupled receptor; Neuropeptide; Nociceptin or Orphanin FQ; ORL1 receptor

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIGAND; MESSENGER RNA; NOCICEPTIN; NOCICEPTIN RECEPTOR; OPIATE RECEPTOR;

BINDING SITE; BRAIN CORTEX; BRAIN STEM; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM; CEREBELLUM; EMOTION; FOREBRAIN; GANGLION; HUMAN; IMMUNE SYSTEM; LIMBIC SYSTEM; MEMORY; MOTONEURON NUCLEUS; NERVE CELL NETWORK; NONHUMAN; OLFACTORY SYSTEM; PERIAQUEDUCTAL GRAY MATTER; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; REVIEW; SENSORY SYSTEM; SMOOTH MUSCLE; SPINAL CORD DORSAL HORN; SPINAL CORD VENTRAL HORN; SUBSTANTIA NIGRA; THALAMUS; TISSUE DISTRIBUTION;

ANIMALS; BINDING SITES; BRAIN STEM; HUMANS; IMMUNE SYSTEM; LIGANDS; MICE; MODELS, BIOLOGICAL; OPIOID PEPTIDES; RATS; RECEPTORS, OPIOID; RNA, MESSENGER; SPINAL CORD; TISSUE DISTRIBUTION; VASODILATOR AGENTS;

EID: 0033821476     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00227-8     Document Type: Review

References (92)

1. Allen C.N., Jiang Z.G., Teshima K., et al. Orphanin-FQ/nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons. J Neurosci. 19:1999;2152-2160.
2. Anton B., Fein J., To T., Li X., Silberstein L., Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J Comp Neurol. 368:1996;229-251.
3. Bunzow J.R., Saez C., Mortrud M., et al. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett. 347:1994;284-288.
4. Butour J.L., Moisand C., Mazarguil H., Mollereau C., Meunier J.C. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids. Eur J Pharmacol. 321:1997;97-103.
5. Butour J.L., Moisand C., Mollereau C., Meunier J.C. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor. Eur J Pharmacol. 349:1998;R5-R6.
6. Calo G., Rizzi A., Bogoni G., et al. The mouse vas deferens a pharmacological preparation sensitive to nociceptin . Eur J Pharmacol. 311:1996;R3-R5.
7. Calo G., Rizzi A., Marzola G., et al. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol. 125:1998;373-378.
8. Champion H.C., Czapla M.A., Kadowitz P.J. Nociceptin, an endogenous ligand for the ORL1 receptor, decreases cardiac output and total peripheral resistance in the rat. Peptides. 18:1997;729-732.
9. Chen Y., Fan Y., Liu J., et al. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347:1994;279-283.
10. Chu X., Xu N., Li P., Wang J.Q. Profound inhibition of cardiomotor neurons in the rat rostral ventrolateral medulla by nociceptin (orphanin FQ). NeuroReport. 9:1998;1081-1084.
11. Connor M., Vaughan C.W., Chieng B., Christie M.J. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br J Pharmacol. 119:1996;1614-1618.
12. Darland T., Grandy D.K. The orphanin FQ system an emerging target for the management of pain? Br J Anaesth. 81:1998;29-37.
13. Darland T, Heinricher MM, Grandy DK. Orphanin FQ/nociceptin. a role in pain and analgesia, but so much more. Trends Neurosci 1998;21:215-21.
14. Devine D.P., Reinscheid R.K., Monsma F.J. Jr, Civelli O., Akil H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727:1996;225-229.
15. Devine D.P., Taylor L., Reinscheid R.K., Monsma F.J. Jr, Civelli O., Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res. 21:1996;1387-1396.
16. Doi N., Dutia M.B., Russell J.A. Inhibition of rat oxytocin and vasopressin supraoptic nucleus neurons by nociceptin in vitro. Neuroscience. 84:1998;913-921.
17. 3H]nociceptin binding site in membrane preparations of rat heart correlations with the non-opioid dynorphin binding site . J Mol Cell Cardiol. 30:1998;2751-2760.
18. Erb K., Liebel J.T., Tegeder I., Zeilhofer H.U., Brune K., Geisslinger G. Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. NeuroReport. 8:1997;1967-1970.
19. Fischer A., Forssmann W.G., Undem B.J. Nociceptin-induced inhibition of tachykinergic neurotransmission in guinea pig bronchus. J Pharmacol Exp Ther. 285:1998;902-907.
20. 3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain. Neurosci Lett. 230:1997;33-36.
21. Florin S., Suaudeau C., Meunier J.C., Costentin J. Nociceptin stimulates locomotion and exploratory behaviour in mice. Eur J Pharmacol. 317:1996;9-13.
22. 14]Orphanin binding to rat brain evidence for labelling the opioid-receptor-like 1 (ORL1) . Neurosci Lett. 230:1997;105-108.
23. Fukuda K., Kato S., Mori K., et al. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 343:1994;42-46.
24. Giuliani S., Lecci A., Tramontana M., Maggi C.A. The inhibitory effect of nociceptin on the micturition reflex in anaesthetized rats. Br J Pharmacol. 124:1998;1566-1572.
25. Giuliani S., Maggi C.A. Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br J Pharmacol. 118:1996;1567-1569.
26. Gouarderes C., Tafani J.A., Meunier J., Jhamandas K., Zajac J. Nociceptin receptors in the rat spinal cord during morphine tolerance. Brain Res. 838:1999;85-94.
27. 2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo. Eur J Pharmacol. 357:1998;R1-R3.
28. Grisel J.E., Mogil J.S., Belknap J.K., Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. NeuroReport. 7:1996;2125-2129.
29. Guerrini R., Calo G., Rizzi A., et al. A new selective antagonist of the nociceptin receptor. Br J Pharmacol. 123:1998;163-165.
30. Gumusel B., Hao Q., Hyman A., Chang J.K., Kapusta D.R., Lippton H. Nociceptin an endogenous agonist for central opioid like1 (ORL1) receptors possesses systemic vasorelaxant properties . Life Sci. 60:1997;L141-L145.
31. Halford W.P., Gebhardt B.M., Carr D.J. Functional role and sequence analysis of a lymphocyte orphan opioid receptor. J Neuroimmunol. 59:1995;91-101.
32. Hao J.X., Wiesenfeld-Hallin Z., Xu X.J. Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat. Neurosci Lett. 223:1997;49-52.
33. Heinricher M.M., McGaraughty S., Grandy D.K. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J Neurophysiol. 78:1997;3351-3358.
34. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand nociceptin/orphanin FQ. Trends Pharmacol Sci. 18:1997;293-300.
35. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., Kumanishi T. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J Comp Neurol. 399:1998;139-151.
36. Jenck F., Moreau J.L., Martin J.R., et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci USA. 94:1997;14854-14858.
37. Jia Y., Linden D.R., Serie J.R., Seybold V.S. Nociceptin/orphanin FQ binding increases in superficial laminae of the rat spinal cord during persistent peripheral inflammation. Neurosci Lett. 250:1998;21-24.
38. Kapusta D.R., Sezen S.F., Chang J.K., Lippton H., Kenigs V.A. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci. 60:1997;L15-L21.
39. Kummer W., Fischer A. Nociceptin and its receptor in guinea-pig sympathetic ganglia. Neurosci Lett. 234:1997;35-38.
40. Kyuhou S., Gemba H. Injection of orphanin FQ/nociceptin into the periaqueductal gray suppresses the forebrain-elicited vocalization in the guinea pig. Neurosci Lett. 260:1999;113-116.
41. Lachowicz J.E., Shen Y., Monsma F.J. Jr, Sibley D.R. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neurochem. 64:1995;34-40.
42. Makman M.H., Dvorkin B. Presence of nociceptin (orphanin FQ) receptors in rat retina comparison with receptors in striatum . Eur J Pharmacol. 338:1997;171-176.
43. Makman M.H., Lyman W.D., Dvorkin B. Presence and characterization of nociceptin (orphanin FQ) receptor binding in adult rat and human fetal hypothalamus. Brain Res. 762:1997;247-250.
44. Mamiya T., Noda Y., Nishi M., Takeshima H., Nabeshima T. Enhancement of spatial attention in nociceptin/orphanin FQ receptor- knockout mice. Brain Res. 783:1998;236-240.
45. Manabe T., Noda Y., Mamiya T., et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature (London). 394:1998;577-581.
46. Meis S., Pape H.C. Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanin FQ. J Neurosci. 18:1998;8133-8144.
47. Meunier J.C. Nociceptin/orphanin FQ, and the opioid receptor-like ORL1 receptor. Eur J Pharmacol. 340:1997;1-15.
48. Meunier J.C., Mollereau C., Toll L., et al. Isolation and structure of the endogenous agonist of opioid receptor- like ORL1 receptor. Nature (London). 377:1995;532-535.
49. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
50. Mollereau C., Parmentier M., Mailleux P., et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
51. Mollereau C., Simons M.J., Soularue P., et al. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci USA. 93:1996;8666-8670.
52. Monteillet-Agius G., Fein J., Anton B., Evans C.J. ORL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing. J Comp Neurol. 399:1998;373-383.
53. Morgan M.M., Grisel J.E., Robbins C.S., Grandy D.K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. NeuroReport. 8:1997;3431-3434.
54. Murphy N.P., Lee Y., Maidment N.T. Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res. 832:1999;168-170.
55. Murphy N.P., Maidment N.T. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J Neurochem. 73:1999;179-186.
56. 14] orphanin FQ binding . J Comp Neurol. 412:1999;563-605.
57. Neal M.J., Cunningham J.R., Paterson S.J., McKnight A.T. Inhibition by nociceptin of the light-evoked release of ACh from retinal cholinergic neurones. Br J Pharmacol. 120:1997;1399-1400.
58. + evoked glutamate release from rat cerebrocortical slices. Br J Pharmacol. 119:1996;1081-1083.
59. Nishi M., Houtani T., Noda Y., et al. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor. EMBO J. 16:1997;1858-1864.
60. Nishi M., Takeshima H., Mori M., Nakagawara K., Takeuchi T. Structure and chromosomal mapping of genes for the mouse κ-opioid receptor and an opioid receptor homologue (MOR-C). Biochem Biophys Res Commun. 205:1994;1353-1357.
61. Nothacker H.P., Reinscheid R.K., Mansour A., et al. Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci USA. 93:1996;8677-8682.
62. Okuda-Ashitaka E., Tachibana S., Houtani T., et al. Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C its involvement in allodynic response to innocuous stimulus . Brain Res Mol Brain Res. 43:1996;96-104.
63. Osinski M.A., Bass P., Gaumnitz E.A. Peripheral and central actions of orphanin FQ (nociceptin) on murine colon. Am J Physiol. 276:1999;G125-G131.
64. Osinski M.A., Pampusch M.S., Murtaugh M.P., Brown D.R. Cloning, expression and functional role of a nociceptin/orphanin FQ receptor in the porcine gastrointestinal tract. Eur J Pharmacol. 365:1999;281-289.
65. Patel H.J., Giembycz M.A., Spicuzza L., Barnes P.J., Belvisi M.G. Naloxone-insensitive inhibition of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by the novel opioid, nociceptin. Br J Pharmacol. 120:1997;735-736.
66. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, Sydney, Australia.
67. Peluso J., LaForge K.S., Matthes H.W., Kreek M.J., Kieffer B.L., Gaveriaux-Ruff C. Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells. J Neuroimmunol. 81:1998;184-192.
68. Reinscheid R.K., Nothacker H.P., Bourson A., et al. Orphanin FQ a neuropeptide that activates an opioidlike G protein-coupled receptor . Science. 270:1995;792-794.
69. Rizzi A., Calo G., Trevisani M., et al. Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus. Life Sci. 64:1999;L157-L163.
70. Saito Y., Maruyama K., Saido T.C., Kawashima S. N23K, a gene transiently up-regulated during neural differentiation, encodes a precursor protein for a newly identified neuropeptide nociceptin. Biochem Biophys Res Commun. 217:1995;539-545.
71. Sandin J., Georgieva J., Schott P.A., Ogren S.O., Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci. 9:1997;194-197.
72. 35S]GTPgammaS binding in comparison with opioid agonist-stimulated ones in brain regions of the mice. Neurosci Lett. 237:1997;113-116.
73. 35S]guanylyl-5′-O-(γ-thio)- triphosphate binding in guinea pig brain. J Comp Neurol. 386:1997;562-572.
74. 35S]GTP gamma S binding in rat brain. NeuroReport. 7:1996;729-733.
75. Sinchak K., Hendricks D.G., Baroudi R., Micevych P.E. Orphanin FQ/nociceptin in the ventromedial nucleus facilitates lordosis in female rats. NeuroReport. 8:1997;3857-3860.
76. Stratford T.R., Holahan M.R., Kelley A.E. Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. NeuroReport. 8:1997;423-426.
77. Sulaiman M.R., Niklasson M., Tham R., Dutia M.B. Modulation of vestibular function by nociceptin/orphanin FQ an in vivo and in vitro study . Brain Res. 828:1999;74-82.
78. Taniguchi H., Yomota E., Nogi K., Onoda Y., Ikezawa K. The effect of nociceptin, an endogenous ligand for the ORL1 receptor, on rat colonic contraction and transit. Eur J Pharmacol. 353:1998;265-271.
79. Tian J.H., Xu W., Fang Y., et al. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia antagonism in brain and potentiation in spinal cord of the rat . Br J Pharmacol. 120:1997;676-680.
80. + conductance in dorsal raphe nucleus neurones. Br J Pharmacol. 117:1996;1609-1611.
81. + conductance. Neuroendocrinology. 67:1998;73-82.
82. Walker J.R., Spina M., Terenius L., Koob G.F. Nociceptin fails to affect heroin self-administration in the rat. NeuroReport. 9:1998;2243-2247.
83. Wang J.B., Johnson P.S., Imai Y., et al. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett. 348:1994;75-79.
84. Wang X.M., Zhang K.M., Mokha S.S. Nociceptin (orphanin FQ), an endogenous ligand for the QRL1 (opioid- receptor-like1) receptor; modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli. J Neurophysiol. 76:1996;3568-3572.
85. Wick M.J., Minnerath S.R., Lin X., Elde R., Law P.Y., Loh H.H. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. Brain Res Mol Brain Res. 27:1994;37-44.
86. Wick M.J., Minnerath S.R., Roy S., Ramakrishnan S., Loh H.H. Expression of alternate forms of brain opioid 'orphan' receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines. Brain Res Mol Brain Res. 32:1995;342-347.
87. 2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci Lett. 249:1998;127-130.
88. Xu X.J., Hao J.X., Wiesenfeld-Hallin Z. Nociceptin or antinociceptin potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat . NeuroReport. 7:1996;2092-2094.
89. Yamamoto T., Nozaki-Taguchi N., Kimura S. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test. Neuroscience. 81:1997;249-254.
90. Yu T.P., Xie C.W. Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms. J Neurophysiol. 80:1998;1277-1284.
91. Zhang G., Murray T.F., Grandy D.K. Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens. Brain Res. 772:1997;102-106.
92. Zhu C.B., Cao X.D., Xu S.F., Wu G.C. Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci Lett. 235:1997;37-40.